Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.52 is 700% above its 5-year average of -0.09, near the high end of its 5-year range (-1.52–0.62).
16.13% below its 12-month average of 0.62.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.16.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:23:10.750Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.52
EARNINGS PER SHARE (EPS) AVG TTM
0.62
EARNINGS PER SHARE (EPS) AVG 3Y
0.43
EARNINGS PER SHARE (EPS) AVG 5Y
-0.09
EARNINGS PER SHARE (EPS) AVG 10Y
-2.66
EARNINGS PER SHARE (EPS) AVG 15Y
-2.49
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.13%
CURRENT VS 3Y AVG
+20.90%
CURRENT VS 5Y AVG
+700.46%
CURRENT VS 10Y AVG
+119.56%
CURRENT VS 15Y AVG
+120.90%
CURRENT VS 20Y AVG
N/A
Puma Biotechnology, Inc.
Market Cap
$483.54M
Earnings Per Share (EPS)
0.52
TTM Avg
0.62
3Y Avg
0.43
5Y Avg
-0.09
Market Cap
$486.01M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.81
3Y Avg
-1.01
5Y Avg
-1.63
Market Cap
$475.91M
Earnings Per Share (EPS)
-1.73
TTM Avg
-1.90
3Y Avg
-1.16
5Y Avg
-1.16
Market Cap
$472.23M
Earnings Per Share (EPS)
-1.99
TTM Avg
-0.88
3Y Avg
-1.91
5Y Avg
-1.95
Market Cap
$471.65M
Earnings Per Share (EPS)
0.16
TTM Avg
-2.02
3Y Avg
-3.99
5Y Avg
-3.80
Market Cap
$471.57M
Earnings Per Share (EPS)
-0.04
TTM Avg
-0.10
3Y Avg
-0.16
5Y Avg
-0.22
Market Cap
$469.12M
Earnings Per Share (EPS)
-0.31
TTM Avg
-0.44
3Y Avg
-0.93
5Y Avg
-0.65
Market Cap
$498.52M
Earnings Per Share (EPS)
-1.76
TTM Avg
-2.31
3Y Avg
-2.36
5Y Avg
-1.76
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Puma Biotechnology, Inc. (PBYI) | $483.54M | 0.52 | 0.62 | 0.43 | -0.09 |
| Evolus, Inc. (EOLS)vs › | $486.01M | -0.52 | -0.81 | -1.01 | -1.63 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | -1.73 | -1.90 | -1.16 | -1.16 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | -1.99 | -0.88 | -1.91 | -1.95 |
| Arvinas, Inc. (ARVN)vs › | $471.65M | 0.16 | -2.02 | -3.99 | -3.80 |
| Cerus Corporation (CERS)vs › | $471.57M | -0.04 | -0.10 | -0.16 | -0.22 |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | -0.31 | -0.44 | -0.93 | -0.65 |
| Oculis Holding AG (OCS)vs › | $498.52M | -1.76 | -2.31 | -2.36 | -1.76 |
| Kamada Ltd. (KMDA)vs › | $467.90M | 0.38 | 0.32 | 0.19 | 0.19 |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.52M | 1.08 | 0.77 | 0.47 | 0.21 |
Trailing EPS (TTM)
$0.52
Forward EPS (Est.)
$0.38
P/E Ratio
18.4
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.62 |
| 2024-12-31 | 0.62 |
| 2023-12-31 | 0.46 |
| 2022-12-31 | 0.02 |
| 2021-12-31 | -0.72 |
| 2020-12-31 | -1.52 |
| 2019-12-31 | -2.13 |
| 2018-12-31 | -2.99 |
| 2017-12-31 | -7.86 |
| 2016-12-31 | -8.29 |
| 2015-12-31 | -7.45 |
| 2014-12-31 | -4.73 |
| 2013-12-31 | -1.90 |
| 2012-12-31 | -3.42 |
| 2011-12-31 | -0.51 |
| 2010-12-31 | -0.01 |
| 2009-12-31 | -0.01 |
| 2008-12-31 | 0.00 |
| 2007-12-31 | -0.38 |
